UTHR

Latest SEC Filings & News for UTHR

2 most recent filings and news items mentioning UTHR. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/UTHR/news?limit=20"

Pull UTHR filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 5, 2026Neutral

United Therapeutics Q2 2026 revenues decline 2% to $783.3M

Total revenues slipped 2% in Q2 2026 to $783.3 million, while net income rose 8% to $333.0 million. The company highlighted record Tyvaso DPI growth and two NDAs submitted for ralinepag and Nebulized Tyvaso in IPF.

View filing at SEC.gov →

OtherJun 29, 2026Neutral

United Therapeutics adopts 2026 Stock Incentive Plan

United Therapeutics adopted the 2026 Stock Incentive Plan to succeed its prior 2015 plan. The new framework will take effect on June 26, 2026, and provides a fresh structure for employee compensation.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.